BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25602252)

  • 21. Fragile x syndrome and elimination disorders in a 6-year-old girl.
    Equit M; Sambach H; von Gontard A
    Klin Padiatr; 2011 Dec; 223(7):430-3. PubMed ID: 21563045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are we anchored to NDT?
    Vansant AF
    Pediatr Phys Ther; 2008; 20(1):1-2. PubMed ID: 18300927
    [No Abstract]   [Full Text] [Related]  

  • 23. New innovations: therapeutic opportunities for intellectual disabilities.
    Picker JD; Walsh CA
    Ann Neurol; 2013 Sep; 74(3):382-90. PubMed ID: 24038210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. People with intellectual disability: what do we know about adulthood and life expectancy?
    Coppus AM
    Dev Disabil Res Rev; 2013; 18(1):6-16. PubMed ID: 23949824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prader-Willi syndrome].
    Sarda P
    Soins Pediatr Pueric; 2013; (274):20-3. PubMed ID: 24228330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination disorders in persons with Prader-Willi and Fragile-X syndromes.
    Equit M; Piro-Hussong A; Niemczyk J; Curfs L; von Gontard A
    Neurourol Urodyn; 2013 Sep; 32(7):986-92. PubMed ID: 23239431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autism spectrum disorders and epigenetics.
    Grafodatskaya D; Chung B; Szatmari P; Weksberg R
    J Am Acad Child Adolesc Psychiatry; 2010 Aug; 49(8):794-809. PubMed ID: 20643313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired theory of mind and symptoms of Autism Spectrum Disorder in children with Prader-Willi syndrome.
    Lo ST; Siemensma E; Collin P; Hokken-Koelega A
    Res Dev Disabil; 2013 Sep; 34(9):2764-73. PubMed ID: 23792373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDD and Prader-Willi syndrome.
    Demb HB; Papola P
    J Am Acad Child Adolesc Psychiatry; 1995 May; 34(5):539-40. PubMed ID: 7775350
    [No Abstract]   [Full Text] [Related]  

  • 30. Bibliography. Current world literature. Developmental disorders.
    Curr Opin Neurol; 2003 Apr; 16(2):221-30. PubMed ID: 12751467
    [No Abstract]   [Full Text] [Related]  

  • 31. [Children and adolescents with developmental disabilities. The spectrum of disorders requires a care team with broad competence].
    Fernell E; Gillberg C
    Lakartidningen; 2007 Apr 4-17; 104(14-15):1126-7. PubMed ID: 17472100
    [No Abstract]   [Full Text] [Related]  

  • 32. Health supervision for children with fragile X syndrome.
    Hersh JH; Saul RA;
    Pediatrics; 2011 May; 127(5):994-1006. PubMed ID: 21518720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical report—health supervision for children with Prader-Willi syndrome.
    McCandless SE;
    Pediatrics; 2011 Jan; 127(1):195-204. PubMed ID: 21187304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family contexts, parental behaviour, and personality profiles of children and adolescents with Prader-Willi, fragile-X, or Williams syndrome.
    van Lieshout CF; De Meyer RE; Curfs LM; Fryns JP
    J Child Psychol Psychiatry; 1998 Jul; 39(5):699-710. PubMed ID: 9690933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome: a randomized controlled trial.
    Reus L; Pelzer BJ; Otten BJ; Siemensma EP; van Alfen-van der Velden JA; Festen DA; Hokken-Koelega AC; Nijhuis-van der Sanden MW
    Res Dev Disabil; 2013 Oct; 34(10):3092-103. PubMed ID: 23886754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent growth failure in Prader-Willi syndrome associated with short-chain acyl-CoA dehydrogenase gene variant.
    Giurgiutiu DV; Espinoza LM; Wood TC; DuPont BR; Holden KR
    J Child Neurol; 2008 Jan; 23(1):112-7. PubMed ID: 18184946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurodevelopmental disabilities in children with intermediate and premutation range fragile X cytosine-guanine-guanine expansions.
    Renda MM; Voigt RG; Babovic-Vuksanovic D; Highsmith WE; Vinson SS; Sadowski CM; Hagerman RJ
    J Child Neurol; 2014 Mar; 29(3):326-30. PubMed ID: 23266944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Unusual disease--tuberous sclerosis].
    Snøløs AK
    Sykepleien; 1989 Jul; 77(12):14-5. PubMed ID: 2474867
    [No Abstract]   [Full Text] [Related]  

  • 39. The neurocutaneous syndromes: diagnosis and management for the primary care pediatrician.
    McIntosh C; Dehkharghani F
    J Ark Med Soc; 1984 Dec; 81(7):354-60. PubMed ID: 6240482
    [No Abstract]   [Full Text] [Related]  

  • 40. Emerging pharmacotherapies for neurodevelopmental disorders.
    Wetmore DZ; Garner CC
    J Dev Behav Pediatr; 2010 Sep; 31(7):564-81. PubMed ID: 20814256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.